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The association ofdrinkingwater arsenic and mortality outcome was investigated in a cohort of
residents from Millard County, Utah. Median drinkingwater arsenic concentrations for selected
study towns ranged from 14 to 166-ppb:andwere.from publicand private samples collected and
analyzed under the auspices ofthe State of Utah Department of Environmental Quality,
Division ofDrinkingWater. Cohort members were assembled usinghistorical documents ofthe
Church ofJesus Christ ofLatter-.day Saints. Standard mortality ratios (SMRs) were calculated.
Using residence history and median drinkingwater arsenic concentration, a matrix for cumula-
tive arsenic exposure was created. Without regard to specific exposure levels, statisticallysignifi-
cant findings include increased mortality from hypertensive heart disease [SMR = 2.20; 95%
confidence interva (CI), 1.36-3.36], nephritis and nephrosis (SMR = 1.72; CI, 1.13-2.50), and
prostate cancer (SMR = 1.45; CI, 1.07-1.91) amongcohortmales.Amongcohortfemales, statis-
ticallysignificant increased mortalitywas foundforhypertensive heart disease (SMR = 1.73; CI,
1.11-2.58) and for the category ofall other heart disease, which indudes pulmonary heart dis-
ease, pericarditis, and other diseases of the pericardium (SMR = 1.43; CI, 1.11-1.80). SMR
analysis by low, medium, and high arsenic exposure groups hinted at a dose relationship for
prostate cancer. Although the SMRs by exposure category were elevated for hypertensive heart
disease for both males and females, the increases were not sequential from low to high groups.
Because the relationship between health effects and exposure to drinking water arsenic is not
well established in US. populations, futher evaluation ofeffects in low-exposure populations is
warranted. Key words: arsenic, cancer, cohort studies, drinking water, epidemiologic studies,
mortality, noncancer, standardized mortality ratio, United States, Utah. Environ HealthPerspect
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The 1996 Safe Drinking Water Act
Amendments (1) mandate that the EPA
revise the current drinking water standard
for arsenic of 50 pg/liter (ppb) by the year
2000. Cross-sectional studies conducted in
Taiwan in the late 1960s (2,3) reported asso-
ciations with blackfoot disease, a vaso-occlu-
sive disorder that has never been reported in
U.S. populations, and skin cancer. Previous
studies of arsenic in drinking water in the
United States have evaluated nonmelanoma
skin cancer (4-8), bladder cancer (9), vascu-
lar disease (10), reproductive effects (11,12),
and toxic effects (13-15). The results from
these studies have been mostly negative. In a
review ofU.S. skin cancer prevalence studies
(16), populations with adequate exposure
and health outcome data had drinking water
arsenic concentrations of <500 ppb. In con-
trast, studies in other countries have indicat-
ed associations with much higher concentra-
tions of arsenic in drinking water supplies
and a wide range ofhealth effects, including
a variety of cardiovascular effects, diabetes
mellitus, and cancer other than skin cancer.
Other investigators in the United States have
presented analyses that suggest larger and
more comprehensive U.S. studies are possi-
ble (9,10).
In the late 1970s the EPA conducted a
small study in Millard County, Utah, on a
population exposed to drinking water with
a mean arsenic concentration of at least
150 ppb (range 53-750 ppb). To conduct
a mortality study, we established a cohort
of Millard County residents based on the
1970s-era studies. The objective ofthe cur-
rent study was to examine the health
effects of chronic consumption of arsenic-
contaminated drinking water in a U.S.
population. This paper describes the results
of an analysis of drinking water arsenic
exposures of <200 ppb and cancer and
noncancer health effects in a U.S. popula-
tion. Results on both cancer and non-
cancer causes ofdeath are presented, along
with drinking water arsenic exposure con-
centrations that consider residence time in
the geographic study area.
Materials and Methods
Cohort assembly. The cohort was assembled
from historical ward membership records of
the Church ofJesus Christ of Latter-day
Saints (LDS) (also known as the Mormons).
These records represent the registry of all
members who ever lived in a ward during a
specific time period. The registers were com-
piled byward members. An LDS church ward
is a defined geographic area whose residents
constitute a single congregation. In this study,
the boundaries of the LDS church wards are
closely aligned with their respective town
boundaries. The wards and years for which the
historical membership books were kept, which
were used in constructing the cohort (i.e.,
enrolling the cohort members), include 1)
Delta for the years 1921-1924 (original ward),
1927-1941 (first ward), 1939-1941 (second
ward), and 1918-1941 (third ward); 2)
Hinckley (1932-1941); 3) Deseret
(1933-1945); 4) Oasis (1900-1945); and 5)
Abraham (1900-1944). Therefore, for individ-
uals entered into the cohort from these records,
the earliest cohort entry date for residence and
follow-up purposes was 1900, and the latest
entry date for an individual was 1945.
Information was recorded on individual char-
acteristics, including name, church ward, fami-
ly relationships, birth date, death date, location
ofdeath, and date that the person moved into
or out ofthat church ward. Follow-up for resi-
dence history for the purpose of estimating
exposure to drinking water arsenic was provid-
ed by LDS church censuses. This is discussed
further in the Arsenic Exposure section.
Additional data were collected from other
sources as follows.
* From the historical LDS church mem-
bership records: name, church ward affili-
ation, birth date, birth town, birth state,
death date, death town, death state, cause
of death, church-related events, gender,
age, spouse name(s), father's name, and
mother's name
* From the LDS church census records:
date of census, name, and residence at
the time ofthe census
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* Current vital status was provided by the
LDS church (these records are updated
by the church on aweekly basis)
* From the LDS Ancestral File (LDS, Salt
Lake City, UT), the International
Genealogical Index (LDS), and the
Social Security Death Index (LDS):
date ofbirth and place ofdeath
* From the death certificates: death date,
death town, death state, underlying
cause ofdeath, and other causes ofdeath
* From the Utah Health Department
(Salt Lake City, UT): information on
the duration ofresidence in the commu-
nity, and coding ofthe underlying cause
of death according to the International
Classification ofDiseases, Ninth Revision
(ICD-9) codes (17).
The cohort was assembled from a 1977
study (14) that consisted of 2,073 cohort
members during the first phase ofdata col-
lection. Most ofthese cohort members had
at least 20 years ofexposure history in their
respective towns. This cohort was expand-
ed in a second phase of data collection to
include all individuals who lived for any
length of time in the study communities.
The second phase ofdata collection result-
ed in a total combined cohort of 4,058
individuals. Cohort members were enrolled
from historical LDS ward registries (18):
1,191 (29.4%) from Delta and 1,192
(29.4%) from Hinckley; the remaining
1,675 (41.2%) were enrolled from histori-
cal ward registries from the surrounding
areas of Deseret, Abraham, and Oasis.
More than 70% had attained the age of60
years at the end ofthe follow-up period or
by the time they were deceased. In all,
2,092 (51.6%) were male and 1,966
(48.5%) were female. At the end of the
cohort assembly in November 1996, 1,551
(38.2%) were alive, 2,203 (54.3%) were
deceased, and 300 (7.4%) were lost to fol-
low-up. Four individuals were younger
than 1 year ofage and were not included in
further analysis. The current analysis focuses
on the 2,203 deceased.
Vital status determinations were made
by the LDS church using current records.
For deceased members, death certificates
were requested from the state where the
death occurred. Because most of the
deceased cohort members died in the State
ofUtah, the Utah Bureau ofVital Records
(BVR; Salt Lake City, UT) provided the
majority of the death certificates. Death
certificates were requested from other states
where cohort members died. The Utah
BVR assisted in the coding ofall death cer-
tificates according to the ICD-9(17).
All death certificates were verified to
ensure a match on identity, gender, and
date ofbirth as compared to the abstracted
information from the historic ward mem-
bership files. Quality control review of the
underlying cause of death was performed
on 10% of death certificates from the ini-
tial phase of the cohort study by a first
nosologist. Cause-of-death codes that were
in question were submitted to a second
nosologist at the National Center for
Health Statistics (Research Triangle Park,
NC), who verified the coding of the first
nosologist. All death certificates collected
in the most recent enrollment were verified
for ICD-9 coding by the first nosologist.
The corrected codes were entered into the
database and used in the analysis.
Water samples. Community drinking
water arsenic concentrations were deter-
mined by historical records ofarsenic mea-
surements in drinking water maintained by
the state ofUtah dating back to 1964.
An overview of arsenic concentrations
in drinking water and source-of-exposure
information for the study area were pre-
sented in a previous feasibility assessment
(18). In the current study, arsenic exposure
levels for the communities were based on
measurements performed by the Utah State
Health Laboratory (Salt Lake City, UT),
which participated in the EPA's quality
assurance program and water quality profi-
ciency testing. In addition, the samples
must have originated from a water source
used for culinary or potable purposes (not
for agricultural or irrigation purposes), and
the location ofthe source ofthe water sam-
ple (i.e., community) had to be clearly
identified. The analysis date must have
been 1976 or later, when the sample collec-
tion method involved acidification of the
collection containers. This resulted in 151
samples ofdrinking water that were used in
assessing the potential exposure of cohort
members to arsenic in drinking water. The
distribution of the concentrations of
arsenic in drinking water in the study com-
munities is provided in Table 1 in order of
highest to lowest median concentration.
Drinking water samples for 60 of the
arsenic concentrations were collected dur-
ing an EPA study in June 1997, with the
rest of the samples dating from 1976 or
later. The Delta water samples came from
the Delta public water system, and samples
from Abraham, Deseret, Oasis, Sugarville,
and Sutherland were taken from private
drinking water wells. No additional water
samples were taken for Hinckley because
the original wells were abandoned in 1981
when a new, low-arsenic source (<50 ppb)
of public drinking water was provided to
Hinckley residents.
Arsenic exposure. Previous studies ofthe
relationship between arsenic in drinking
water and health effects have used a cumula-
tive exposure index in which the overall
exposure to arsenic for each subject is the
product of the length of residence and the
concentration of arsenic in drinking water
(19,20). Using similar methods, an arsenic
exposure index score was calculated for each
individual in the cohort. The exposure index
was derived from the number ofyears ofres-
idence in the community and the median
arsenic concentration of drinking water
arsenic in the community. Residence was
determined by the members' entry into his-
torical LDS church censuses, which the
church conducted roughly every 5 years
between 1914 and 1962 to determine where
individual members lived throughout the
world. Census years were 1914, 1920, 1925,
1930, 1935, 1940 (1945 skipped), 1950,
1955, 1960, and 1962. Data extracted from
the censuses included date of census and
residence at the time ofthe census.
The arsenic exposure index scores are
expressed as ppb-years and are calculated as
follows:
E. = X(D x A) = ppb-years
where E = exposure index score value for
individual i in ppb-years, D = duration of
residence in years in community xfor indi-
vidual i, andA = median arsenic concentra-
tion in drinking water for community x
in ppb.
The arsenic exposure index was catego-
rized as low (<1,000 ppb-years), medium
(1,000-4,999 ppb-years), and high (>5,000
ppb-years). The rationale for this categoriza-
tion is that20 years ofexposure is a reasonable
Table 1. Distribution of arsenic drinking water concentrations from historical and recent arsenic mea-
surementdata forUtah communities in the study area
Town Number Median Mean Min Max SD
Hinckley 21 166 164.4 80 285 48.1
Deseret 37 160 190.7 30 620 106.6
Abraham 15 116 134.2 5.5 310 67.2
Sugarville 6 92 94.5 79 120 15.3
Oasis 7 71 91.3 34 205 57.8
Sutherland 19 21 33.9 8.2 135 31.8
Delta 46 14 18.1 3.5 125 17.7
Abbreviations: Mint mimimum arsenic concentration (ppb); Max, maximum arsenic concentration (ppb); SD, standard
deviation.
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period for most cancers to become manifest
and an exposure to drinking water with 50
ppb arsenic or higher will yield a cumulative
arsenicexposureof1,000 ppb-years.
Analysis. Basic distributions of selected
variables were made using SAS statistical
software (21). The cohort data analysis uses
standardized mortality ratios (SMRs) as the
measure of association (22). The OCMAP
program (23), adapted to a nonoccupation-
al cohort, was used to compare the observed
number of deaths with the expected num-
ber of deaths generated from death rates
from the white male and white female gen-
eral population of Utah within a given
underlying cause ofdeath category. Because
a review ofthe race variable entered on the
death certificates showed that all deceased
individuals were white, death rates forwhite
males and white females were used. Death
rates for the state ofUtah were available for
the years 1960-1992 for diseases other than
cancer, and from 1950 to 1992 for cancers.
The death rates were applied in 5-year
increments, with the exception of the
1990-1992 period. For those who died of
causes other than cancer before 1960, the
1960-1964 death rates for causes other
than cancer were applied. Similarly, for
those who died of cancer before 1950, the
1950-1954 cancer death rates were applied.
For those who died after 1992, the
1990-1992 death rates for either the cancer
or noncancer cause of death were applied.
To accommodate the needs of the pro-
gram, a 1-year lag was imposed. This
resulted in the exclusion of children less
than 1 year old from the analysis (n = 4).
At the end of the study, an individual was
censored from the analysis on the date of
death ifdeceased, the end ofstudy date (27
November 1996) if alive, or at the last
known residence date if lost to follow-up.
The end date ofthe study was based on the
time when the last vital status determina-
tion was made on the last batch ofrecords
provided by the LDS church. LDS church
records are updated weekly.
Results
Table 2 shows the distribution of basic
demographic factors and arsenic exposure
index distribution for the 2,203 deceased
individuals with residence data. For non-
cancer outcomes among males (Table 3),
deaths from hypertensive heart disease [SMR
= 2.20; 95% confidence interval (CI),
1.36-3.36] and nephritis and nephrosis
(SMR = 1.72; CI, 1.13-2.50) were signifi-
cantly elevated in the cohort as compared to
the mortality experience for Utah white
males. Death from arteriosclerosis (SMR =
1.24; CI, 0.69-2.04) and benign neoplasms
(SMR = 1.05; CI, 0.29-2.69) was increased,
but not statistically significant. Death from
other cardiovascular causes (including cere-
brovascular disease and ischemic heart dis-
ease) and respiratory causes (including non-
malignant respiratory disease; bronchitis,
emphysema, and asthma; and other respira-
tory disease) was significantly decreased as
compared to the expected number ofdeaths
for white males in the state ofUtah. Among
females (Table 3), death due to hypertensive
heart disease (SMR = 1.73; CI, 1.11-2.58)
and to all other heart disease (SMR = 1.43;
CI, 1.11-1.80) was significantly elevated as
compared to Utah white females. Deaths due
to benign neoplasms (SMR = 1.96; CI,
0.85-3.86), diabetes mellitus (SMR = 1.23;
CI, 0.86-1.71), arteriosclerosis (SMR =
1.18; CI, 0.68-1.88), and nephritis and
nephrosis (SMR = 1.21; CI, 0.66-2.03) were
increased. Deaths from ischemic heart dis-
ease and all external causes ofdeath were less
than thatexperienced byUtah white females.
To assess whether an increased expo-
sure to drinking water arsenic could affect
Table 2. Demographic distribution and arsenic exposure categories for deceased individuals in the
Millard County, Utah, mortality cohort
Low Medium High
<1,000 ppb-years 1,000-4,999 ppb-years .5,000 ppb-years
n % n % n % Total
Age at death
<50 171 18.1 102 14.6 34 6.1 307
50-59 88 9.3 84 12.0 40 7.2 212
60-69 173 18.3 144 20.6 92 16.5 409
70-79 259 27.4 209 29.9 182 32.7 650
80+ 255 27.0 161 23.0 209 37.5 625
Gender
Male 536 56.7 415 59.3 291 52.2 1,242
Female 410 43.3 285 40.7 266 47.8 961
Years in cohort
<40 401 42.4 276 39.4 59 10.6 736
40-59 335 35.4 197 28.1 153 27.5 685
60-69 147 15.5 102 14.6 101 18.1 350
70+ 63 6.7 125 17.9 244 43.8 432
Total 946 - 700 - 557 - 2,203
mortality, SMRs were analyzed according
to low, medium, and high arsenic exposure
index values. Although the SMRs for
hypertensive heart disease were elevated for
males and females, the increases in the
SMRs for low, medium, and high expo-
sures did not increase sequentially. Other
causes of death with elevated SMRs
(nephritis and nephrosis for males and
females, and all other heart disease for
females) had elevated SMRs mostly in the
medium or low arsenic exposure index cat-
egories. Causes of death with significantly
decreased SMRs mostly had decreased
SMRs within the low, medium, and high
arsenic exposure index categories (e.g.,
cerebrovascular disease, all heart disease,
and ischemic heart disease); however, the
decreases did not descend sequentially from
the high to low categories.
SMRs for cancer causes ofdeath are listed
for males and females in Table 4. Among
males, prostate cancer was significantly
increased (SMR = 1.45; CI, 1.07-1.91). Death
due to kidney cancer (SMR = 1.75; CI,
0.80-3.32) was elevated in the medium and
high exposure groups. Males in the mortality
cohorthadsignificandy less mortalitydue to all
malignant cancers and cancer ofthe digestive
organs and peritoneum, large intestine, and
respiratory system than Utah white males.
Mortality from lymphatic and haematopoietic
cancers was decreased for both males and
females. There were no cancer causes ofdeath
for females that were significantly elevated;
however, moderate elevations in death due to
cancer ofthe biiary passages and liver (SMR =
1.42; CI, 0.57-2.93), kidney cancer (SMR =
1.60; CI, 0.44-4.11), melanoma of the skin
(SMR = 1.82; CI, 0.50-4.66), and all other
malignant neoplasms (SMR = 1.34; CI,
0.84-2.03) are noted. Females in the mortality
cohort had significantly less death due to all
malignant neoplasms, cancers ofthe digestive
organs and peritoneum, pancreas, respiratory
system, and breast than did Utah white
females. Mortality from uterine cancer and
otherfemalegenital cancerswasalso decreased.
Among cancer causes ofdeath for males,
SMRs for the arsenic exposure index cate-
gories remained consistently elevated for
prostate cancer, with the medium and high
SMRs ofsimilar magnitude and higher than
the low group. Although the SMRs for low,
medium, and high arsenic exposures for kid-
ney cancer were elevated for males and
females, the increases did not risesequentially
from low to high drinking water arsenic con-
centrations.
Discussion
Previous studies of drinking water arsenic
concentration and health effects have
indicated that skin cancer (2,3,24,25),
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internal cancers (25-35), cardiovascular populations with markedly higher drinking comparable exposures to arsenic in drinking
effects (10,19,20,29,36), diabetes mellitus water exposures that can exceed 2,000 ppb. water. In general, the highest exposures in
(34,37,38), and potentially neurologic effects Although the Taiwan studies (2,3) U.S. studies are similar to the lowest expo-
(7,39) are linked with ingestion of increased linked skin cancer and blackfoot disease sures (or control exposures) in studies from
concentration ofdrinkingwater arsenic. Most with very high exposures, there are few other countries. The generalizability of the
of these studies were conducted in non-U.S. individuals in the U.S. population with results from the Taiwan studies to the U.S.
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general population has been questioned
(40), as the lowest exposure category
includes concentrations of up to 290 ppb
(41). It is estimated that approximately
200,000 individuals are exposed to drinking
water arsenic concentrations above 50 ppb
(42). The median concentration of arsenic
in drinking water in the Millard County
mortality study is <200 ppb, and exposure
to arsenic in drinking water could be
regarded as typical of those concentrations
ofarsenic found in drinking water supplies
in the United States. There are consistencies
in the kinds ofhealth effects that have asso-
ciations in this study and in other interna-
tional studies; however, the results of the
present study need to be considered in the
full context ofall epidemiologic results cur-
rently available.
The major strength ofthis study is that
it examines the effects of chronic exposure
to arsenic in a U.S. population. Advantages
ofthe cohort design include that the expo-
sure precedes the effect, and that cohort
studies have the capability to provide infor-
mation on a variety ofhealth effects from a
single exposure (22). While the exposure is
ecologic, i.e., not tied to an individual's
actual consumption, the arsenic exposure
estimates are believed to be accurate and
the exposure is believed to have remained
constant over time. During this study, the
investigators were able to gather a consider-
able number ofarsenic concentrations from
private wells, so that estimates ofexposure
to arsenic from drinking water for individ-
uals may be possible in future studies.
Although individual data on confounding
factors are not available, the historic mem-
bership of the cohort in the LDS church
permits some assumptions regarding per-
sonal lifestyle including prohibition of
tobacco use and of the consumption of
alcohol or caffeine. Because church policy
dictates that membership registration
records are placed in the church ward of a
member's residence, there is a high degree
of confidence that the cohort members
were exposed to the concentrations of
drinking water arsenic for the communities
in which they resided. Although the period
ofresidence in the study area for the cohort
members exceeds the period of available
exposure information, historical documents
indicate that drinking water quality has not
changed considerably because of 100%
reliance on groundwater supplies (18).
Other U.S. studies have not had the
advantage of more population-specific
arsenic monitoring data. A previous study
(101 estimated the concentration ofarsenic
in drinking water in Millard County was
9.3 ppb. However, this estimate was based
on a population-weighted mean arsenic
concentration in the public water supply
data from the state ofUtah. Because many
residents of Millard County relied on pri-
vate wells with much higher concentrations
ofarsenic, this estimate is not accurate.
Associations of drinking water arsenic
with cardiovascular diseases, including
hypertension (19), arteriosderosis (29), cere-
brovascular disease (36), ischemic heart dis-
ease (20), and other vascular diseases
(10,35,43), have been reported. It has been
hypothesized that exposure to arsenic in
drinking water may be directly linked to
ischemic heart disease and blackfoot disease
via the atherogenic pathway (44). Indirect
effects ofarsenic on other cardiovascular risk
factors including hypertension and diabetes
(19,36) have also been proposed. Arsenic
has been associated with vascular lesions
including angiosarcomas and atherosclerotic
plaques, suggesting that arsenic plays a role
in somatic mutations and cell proliferation
in the etiology of atherosclerotic plaques
(45). In the currentstudy, increased associa-
tions for hypertension and arteriosclerosis
were found for both males and females.
Death from all other heart disease in females
was increased. This category included pul-
monary heart disease, pericarditis, and other
diseases ofthe pericardium.
The findings ofcardiovascular effects in
the context of a dose-response relationship
with drinking water arsenic in this analysis
are less clear. Although SMRs cannot be
directly compared in an analysis that uses
indirect adjustment, trends may be
observed ifthe age and gender distributions
in the exposure groups are similar. In Table
2, the age distributions are not similar (chi-
square = 48.4, 8 degrees of freedom,
p<0.01), but the gender distributions are
similar (chi-square = 1.9, 2 degrees of free-
dom, p = 0.17). Based on this, any conclu-
sions on whether arsenic is an etiologic fac-
tor in consideration of increased or
decreased SMRs among the groups is
uncertain. Further evaluation of the rela-
tionship ofeach ofthese cardiovascular dis-
eases with drinkingwater arsenic in this and
other populations is needed. Positive associ-
ations with diabetes mellitus and the con-
centration ofarsenic in drinking water have
been reported in India, Bangladesh, and
Argentina (34,37,38). In this study, there is
no clear indication of any relationship
between the concentration of arsenic in
drinking water and diabetes mellitus.
Associations for nonmalignant respira-
tory diseases and bronchitis, emphysema,
and asthma combined were also decreased,
possibly indicating that the respiratory
health ofthe cohort was good and smoking
was not a major factor. Death from respira-
tory cancers was decreased significantly for
both males and females. Because the cohort
was assembled based on historic LDS
records, it is believed that the cohort was
largely nonsmoking, as smoking is prohibit-
ed by the LDS church. Annual smoking
prevalence rates for the state of Utah
between 1984 and 1996 indicate that Utah
consistently had the lowest prevalence of
smoking among all states reporting, ranging
from 13.2 to 16.8% among adults aged 18
years and older (46). Smoking rates for the
Central Utah Health District, which
includes Millard County, reported an aver-
age smoking rate among adults 18 and
older of 13% for 1996 (47). During the
same year, the entire state of Utah had a
smoking prevalence of 12.4% and Salt Lake
Countyhad a smokingprevalence of13.9%
(47). For the incidence of cancers that are
strongly related to smoking (including oral
cavity, larynx, lung, esophagus, and bladder
cancers), Mormon men had cancer inci-
dence rates over a 15-year period from
1971 to 1985 that were approximately half
those for U.S. men (48).
The current results indicating a positive
association with prostate cancer are intrigu-
ing as this is the first known potential associ-
ation between exposure to arsenic in drink-
ing water and prostate cancer in the United
States. In this analysis, prostate cancer was
also the only health outcome that appeared
to have a dose-response effect based on the
low, medium, and high exposure index cate-
gories. The etiology of prostate cancer is
largely unknown; however, it is believed that
hormonal factors, familyhistory, and dietary
practices are involved (49). The incidence
and mortality of prostate cancer increase
dramatically after age 40. Worldwide,
prostate cancer has the lowest rates among
Chinese and Japanese men (50), with
African-American men and Caucasian pop-
ulations from North America experiencing
the highest incidence rates. Mortality is
lower in the United States as compared to
high-risk countries (51). The ethnic back-
groundofthe Millard Countystudypopula-
tion is primarily English, Scottish, and
Scandinavian. For prostate cancer, Mormons
have about a 10-15% higher incidence rate
than U.S. men (48,52). Familial history is a
strong risk factor for prostate cancer, as
indicated by the results ofa previous family
study that also utilized Mormon records
(53). In contrast, associations with mortality
from cancers of the female reproductive
tract in the Millard County mortality cohort
were largely negative.
Previous studies from an endemic area
of chronic arsenic toxicity in Taiwan
(9,32,33,35) and an ecologic study in
Argentina (26) have reported associations
for increased exposure to drinking water
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arsenic and risk for bladder cancer. A
case-control study ofbladder cancer in Utah
(9) did not find an association with ingested
arsenic, and in the Millard County mortality
study only five deaths were due to bladder
cancer. Whereas the studies in Taiwan and
Argentina reported high exposures to drink-
ing water arsenic, this study population was
exposed to much lower levels, perhaps indi-
cating that bladder cancer occurs in response
to higher arsenic concentrations. In reviewing
other causes of death from the urinary sys-
tem, death from kidney cancer and nephritis
and nephrosis were consistently elevated in
both males and females. However, the SMRs
did not increase with increasing levels of
exposure. Other subclassifications ofthe types
of nephritis and nephrosis were not available
for the analysis, but competing causes such as
infections need to be ruled out.
An increase in mortality due to
melanoma in the lowest exposure category
was found among females. Although skin
cancer is etiologically linked with arsenic in
drinking water, melanoma is not the histo-
logic type of skin cancer usually associated
with arsenic intake (54). In females, all ofthe
melanoma deaths occurred in the lowest
exposure category where the expected num-
ber was less than one. Based on these small
numbers, it is not possible to draw conclu-
sions about any involvement of exposure to
arsenic in drinking water with this finding.
Alternatively, continued follow-up of the
cohort in the future could clarifywhether the
association between arsenic exposure and
melanoma disappears. In contrast, the results
for melanoma among males were negative.
Based on these cohort data, we do not
believe that loss to follow-up, confounding, or
multiple comparisons played a significant role
in these results. Based on their review ofseveral
cohort studies, Breslow and Day (55) noted
that loss to follow-up is acceptable if it is
<10%. Our loss to follow-up is 7.4%. The dis-
tribution of this group by drinking water
arsenic exposure was 163 in the low-exposure
group, 96 in the medium-exposure group, and
41 in the high-exposure group. Because the net
effect of loss to follow-up is to bias results
toward the null value (55), and because most
of the loss to follow-up is already in the low
group in this cohort, the impact on our results
would be to attenuate any observed effects
rather than to spuriously increase them.
In this study, potential exposure to
atmospheric arsenic is the most likely con-
founder because this variable is related both
to health effects in previous studies ofmin-
ers (56,57) and is associated with availabili-
ty in sediments as a result of mining (58).
Although data on atmospheric arsenic con-
centration was sought from the state of
Utah to address potential confounding
effects from this alternate exposure to
arsenic, this type of data is not routinely
collected. However, future studies involv-
ing arsenic exposure assessment will consid-
er atmospheric arsenic data collection.
Because the study region in Millard
County is primarily agricultural or vast
desert with no mining activity, we do not
believe a significant part of the exposure to
arsenic was due to atmospheric exposure.
Because most of the significant associa-
tions we found in this analysis have been
found by others and were not unanticipat-
ed, we do not believe multiple comparisons
ofexposure and outcome in these data rep-
resent a problem. To adjust for multiple
comparisons would be incorrect because the
correction theory is based on the universal
null hypothesis that chance serves as the
explanation for observed associations (59).
Associations with hypertension and prostate
cancer have been reported elsewhere
(19,35). The association with nephritis and
nephrosis is worthy offurther investigation.
Human autopsy data do not suggest arsenic
accumulates more in the kidney than in
other internal tissues (60,61). Although it is
unknown whether the kidney represents a
site of injury of arsenic, arsenate has been
taken up by the phosphate carrier in cells of
the proximal convoluted tubule (62).
In conclusion, this study represents a
unique opportunity for health researchers
to better understand the potential for
health effects in association with relatively
low exposure to arsenic in drinking water
in a U.S. population. Although cohort
members contributed many years to the
highly exposed group and some died at an
advanced age with no perceived adverse
effects, further examination of this cohort
is planned. Additional analysis of the data
continues and includes a Cox proportional
hazards analysis that will allow internal
comparisons to be made between high,
medium, and low exposure categories.
Results from this study are important in
the context of the ongoing review of the
U.S. drinking water arsenic standard. This
study will provide some insight into the
role of both noncarcinogenic end points
and carcinogenic end points in the review
of the drinking water arsenic standard.
Data from this cohort study will be espe-
cially useful in evaluating hazard identifica-
tion and will provide some information on
potential dose-response relationships as
specified in the risk assessment paradigm.
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